In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors

Mahmoud A. A. Ibrahim(Minia University), Mohamed‐Elamir F. Hegazy(Kyoto Pharmaceutical University), Khaled S. Allemailem(Qassim University), Ahmad Almatroudi(Qassim University), Mahmoud Moustafa(South Valley University), Alaa H. M. Abdelrahman(Minia University)
The Protein Journal
January 2, 2021
10.1007/s10930-020-09945-6
Cited by 62

Related Papers

Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications
|3 Biotech|2020|221
The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active Metabolism
|Endocrine Metabolic & Immune Disorders - Drug Targets|2019|184
Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways
|Molecules|2021|176
Bee Pollen: Current Status and Therapeutic Potential
|Nutrients|2021|168
Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer’s Disease
|Oxidative Medicine and Cellular Longevity|2022|128